Study of PF-07248144 in Advanced or Metastatic Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of PF-07248144 in Advanced or Metastatic Solid Tumors	Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Recruiting	Phase 2	2026-04-16		NCT04606446

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Pfizer	431

44 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Aichi Cancer Center Hospital	Nagoya	Japan	30
Asan Medical Center	Seoul	South Korea	338
Beijing Cancer Hospital	Beijing	China	208
Cancer Research South Australia	Adelaide	Australia	11
Cedars Sinai Medical Center	Los Angeles	United States	135
Cedars-Sinai Cancer at Cedars-Sinai Medical Center	Los Angeles	United States	6
Chris O'Brien Lifehouse	Camperdown	Australia	46
Holy Cross Hospital	Fort Lauderdale	United States	125
HonorHealth	Scottsdale	United States	21
Jilin Province Tumor Hospital	Changchun	China	2
Jilin Province Tumor Hospital	Changchun	China	1
Kanagawa cancer center	Yokohama	Japan	18
Kyungpook National University Chilgok Hospital	Daegu	South Korea	7
MD Anderson	Sugar Land	United States	1
MD Anderson League City	League City	United States	33
MD Anderson The Woodlands	Conroe	United States	1
MD Anderson West Houston	Houston	United States	40
National Cancer Center Hospital	Chuo-ku	Japan	67
National Cancer Center Hospital East	Kashiwa	Japan	67
NEXT Oncology	San Antonio	United States	70
Peter MacCallum Cancer Centre	Melbourne	Australia	149
Royal Melbourne Hospital	Parkville	Australia	39
Samsung Medical Center	Seoul	South Korea	37
Scri Oncology Partners	Nashville	United States	156
Seoul National University Bundang Hospital	Seongnam-si	South Korea	107

Clinical trials